MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20247109

May 22, 2024

国药准字H20213567

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1%(0.4ml: 0.4mg)

化学药品

May 22, 2024

Company Information

Applicant Company

中山市南朗镇华南现代中医药城科创园2号厂房第1层

Manufacturing Company

广东省中山市南朗镇华南现代中医药城思邈路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath